This federal contract award, identified as SPE2DB20D3101 and SPE2DB25FQWX3, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Valsartan-HCTZ 160-25 mg tablets in 90-count packages, with a ceiling value of $1,067.90 and a completion date of December 13, 2024.
The contract is a delivery order, with a firm fixed-price pricing type, and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor for this award, which is a child contract under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Generated 3/13/25, 9:58 AM